Lachlan Brown
Stock Analyst at William Blair
(0.42)
# 3,583
Out of 4,828 analysts
8
Total ratings
28.57%
Success rate
-14.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lachlan Brown
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KLRS Kalaris Therapeutics | Initiates: Outperform | n/a | $3.48 | - | 1 | Apr 8, 2025 | |
| OCUL Ocular Therapeutix | Initiates: Outperform | n/a | $7.06 | - | 1 | Apr 8, 2025 | |
| SNPS Synopsys | Initiates: Buy | $600 | $482.90 | +24.25% | 1 | Jan 13, 2025 | |
| CDNS Cadence Design Systems | Initiates: Buy | $350 | $305.78 | +14.46% | 1 | Jan 13, 2025 | |
| APLS Apellis Pharmaceuticals | Initiates: Outperform | n/a | $17.30 | - | 1 | Oct 16, 2024 | |
| DSGX The Descartes Systems Group | Initiates: Neutral | $90 | $107.46 | -16.25% | 1 | May 14, 2024 | |
| MANH Manhattan Associates | Initiates: Buy | $260 | $184.37 | +41.02% | 1 | May 14, 2024 | |
| SPSC SPS Commerce | Initiates: Buy | $220 | $143.87 | +52.92% | 1 | May 14, 2024 |
Kalaris Therapeutics
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $3.48
Upside: -
Ocular Therapeutix
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $7.06
Upside: -
Synopsys
Jan 13, 2025
Initiates: Buy
Price Target: $600
Current: $482.90
Upside: +24.25%
Cadence Design Systems
Jan 13, 2025
Initiates: Buy
Price Target: $350
Current: $305.78
Upside: +14.46%
Apellis Pharmaceuticals
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $17.30
Upside: -
The Descartes Systems Group
May 14, 2024
Initiates: Neutral
Price Target: $90
Current: $107.46
Upside: -16.25%
Manhattan Associates
May 14, 2024
Initiates: Buy
Price Target: $260
Current: $184.37
Upside: +41.02%
SPS Commerce
May 14, 2024
Initiates: Buy
Price Target: $220
Current: $143.87
Upside: +52.92%